Skip to main content
OpenTrials

Clinical trial condition

Cholestasis

Explore clinical trials studying Cholestasis. Study availability and eligibility vary by location and protocol.

179 public trials 39 recruiting studies
Refine in advanced search Browse all conditions

Cholestasis trial results

Active, not recruiting

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

NCT03301506

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Arkansas Diagnostic Center Little Rock, Arkansas, United States
  • Stanford University School of Medicine Palo Alto, California, United States
  • California Liver Research Institute Pasadena, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
View all 109 locations
View Trial Details
Active, not recruiting

CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)

NCT05896124

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • The First Affiliated Hospital of USTC Anhui Provincial Hospital Hefei, Anhui, China
  • Beijing Friendship Hospital, Capitai Medical University Beijing, Beijing Municipality, China
  • Beijing Youan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View all 16 locations
View Trial Details
Active, not recruiting

Liver Cirrhosis Network Cohort Study

NCT05740358

Conditions
Alcohol-Induced Disorders, Alcohol-Related Disorders, Autoimmune Diseases, +34 more
Locations
  • University of California San Diego NAFLD Research Center La Jolla, California, United States
  • Keck Medical Center of USC Los Angeles, California, United States
  • LAC + USC Medical Center Los Angeles, California, United States
  • UCSF/Zuckerberg San Francisco General Hospital and Trauma Center San Francisco, California, United States
View all 14 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.

NCT06247735

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • UA Thomas D. Boyer Liver Institute Tucson, Arizona, United States
  • Southern California Research Center - Coronado Coronado, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Velocity Clinical Research Santa Ana, California, United States
View all 38 locations
View Trial Details
Completed

Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC

NCT05239468

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Southern California Gastrointestinal (GI) and Liver Centers (SCLC) - Coronado Coronado, California, United States
  • Facey Medical Group Mission Hills, California, United States
  • Schiff Center for Liver Diseases / University of Miami Miami, Florida, United States
View all 26 locations
View Trial Details
Completed

A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.

NCT06383403

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Southern California Research Center Coronado, California, United States
  • Topgraphy Health, Inc. Los Angeles, California, United States
  • University of California, Davis Sacramento, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 60 locations
View Trial Details

Related conditions